Relative Binding Free Energy Calculations Applied to Protein Homology Models

A significant challenge and potential high-value application of computer-aided drug design is the accurate prediction of protein-ligand binding affinities. Free energy perturbation (FEP) using molecular dynamics (MD) sampling is among the most suitable approaches to achieve accurate binding free energy predictions, due to the rigorous statistical framework of the methodology, correct representation of the energetics, and thorough treatment of the important degrees of freedom in the system (including explicit waters). Recent advances in sampling methods and force fields coupled with vast increases in computational resources have made FEP a viable technology to drive hit-to-lead and lead optimization, allowing for more efficient cycles of medicinal chemistry and the possibility to explore much larger chemical spaces. However, previous FEP applications have focused on systems with high-resolution crystal structures of the target as starting points-something that is not always available in drug discovery projects. As such, the ability to apply FEP on homology models would greatly expand the domain of applicability of FEP in drug discovery. In this work we apply a particular implementation of FEP, called FEP+, on congeneric ligand series binding to four diverse targets: a kinase (Tyk2), an epigenetic bromodomain (BRD4), a transmembrane GPCR (A2A), and a protein-protein interaction interface (BCL-2 family protein MCL-1). We apply FEP+ using both crystal structures and homology models as starting points and find that the performance using homology models is generally on a par with the results when using crystal structures. The robustness of the calculations to structural variations in the input models can likely be attributed to the conformational sampling in the molecular dynamics simulations, which allows the modeled receptor to adapt to the "real" conformation for each ligand in the series. This work exemplifies the advantages of using all-atom simulation methods with full system flexibility and offers promise for the general application of FEP to homology models, although additional validation studies should be performed to further understand the limitations of the method and the scenarios where FEP will work best.

[1]  B. Matthews,et al.  A model binding site for testing scoring functions in molecular docking. , 2002, Journal of molecular biology.

[2]  Jonathan W. Essex,et al.  Prediction of protein–ligand binding affinity by free energy simulations: assumptions, pitfalls and expectations , 2010, J. Comput. Aided Mol. Des..

[3]  David L Mobley,et al.  An introduction to best practices in free energy calculations. , 2013, Methods in molecular biology.

[4]  Niu Huang,et al.  Physics-Based Scoring of Protein-Ligand Complexes: Enrichment of Known Inhibitors in Large-Scale Virtual Screening , 2006, J. Chem. Inf. Model..

[5]  Claudio N. Cavasotto,et al.  Handling Protein Flexibility in Docking and High‐Throughput Docking: From Algorithms to Applications , 2011 .

[6]  B. Shoichet,et al.  Decoys for docking. , 2005, Journal of medicinal chemistry.

[7]  Woody Sherman,et al.  Improving the Prediction of Absolute Solvation Free Energies Using the Next Generation OPLS Force Field. , 2012, Journal of chemical theory and computation.

[8]  W. L. Jorgensen Efficient Drug Lead Discovery and Optimization , 2009 .

[9]  B. Berne,et al.  Replica exchange with solute scaling: a more efficient version of replica exchange with solute tempering (REST2). , 2011, The journal of physical chemistry. B.

[10]  William B. Smith,et al.  Selective inhibition of BET bromodomains , 2010, Nature.

[11]  Matthew P. Repasky,et al.  Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. , 2004, Journal of medicinal chemistry.

[12]  Jennifer L. Knight,et al.  Modeling Local Structural Rearrangements Using FEP/REST: Application to Relative Binding Affinity Predictions of CDK2 Inhibitors. , 2013, Journal of chemical theory and computation.

[13]  B. Shoichet,et al.  Soft docking and multiple receptor conformations in virtual screening. , 2004, Journal of medicinal chemistry.

[14]  W. L. Jorgensen,et al.  Design, synthesis, and protein crystallography of biaryltriazoles as potent tautomerase inhibitors of macrophage migration inhibitory factor. , 2015, Journal of the American Chemical Society.

[15]  P Kolb,et al.  GPCRdb: the G protein‐coupled receptor database – an introduction , 2016, British journal of pharmacology.

[16]  David L Mobley,et al.  Predicting ligand binding affinity with alchemical free energy methods in a polar model binding site. , 2009, Journal of molecular biology.

[17]  Rebecca C. Wade,et al.  COMPUTATIONAL ALCHEMY TO CALCULATE ABSOLUTE PROTEIN-LIGAND BINDING FREE ENERGY , 1998 .

[18]  Giovanni Piersanti,et al.  2-n-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine and analogues as A2A adenosine receptor antagonists. Design, synthesis, and pharmacological characterization. , 2005, Journal of medicinal chemistry.

[19]  R. Friesner,et al.  Novel procedure for modeling ligand/receptor induced fit effects. , 2006, Journal of medicinal chemistry.

[20]  William L. Jorgensen,et al.  FEP-guided selection of bicyclic heterocycles in lead optimization for non-nucleoside inhibitors of HIV-1 reverse transcriptase. , 2006 .

[21]  K. Dill,et al.  Predicting absolute ligand binding free energies to a simple model site. , 2007, Journal of molecular biology.

[22]  Cristiano Ruch Werneck Guimarães,et al.  MM-GB/SA Rescoring of Docking Poses in Structure-Based Lead Optimization , 2008, J. Chem. Inf. Model..

[23]  William L. Jorgensen,et al.  Free energy calculations: a breakthrough for modeling organic chemistry in solution , 1989 .

[24]  B. Roux,et al.  Computational Study of the “DFG-Flip” Conformational Transition in c-Abl and c-Src Tyrosine Kinases , 2014, The journal of physical chemistry. B.

[25]  Thomas Fox,et al.  Accuracy Assessment and Automation of Free Energy Calculations for Drug Design , 2014, J. Chem. Inf. Model..

[26]  B. Berne,et al.  Replica exchange with solute tempering: a method for sampling biological systems in explicit water. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[27]  David L Mobley,et al.  Alchemical free energy methods for drug discovery: progress and challenges. , 2011, Current opinion in structural biology.

[28]  Hege S. Beard,et al.  Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. , 2004, Journal of medicinal chemistry.

[29]  Woody Sherman,et al.  Predicting Binding Affinities for GPCR Ligands Using Free-Energy Perturbation , 2016, ACS omega.

[30]  Hwangseo Park,et al.  Homology modeling, force field design, and free energy simulation studies to optimize the activities of histone deacetylase inhibitors , 2004, J. Comput. Aided Mol. Des..

[31]  Jennifer L. Knight,et al.  OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins. , 2016, Journal of chemical theory and computation.

[32]  Christoph A. Sotriffer,et al.  The Challenge of Affinity Prediction: Scoring Functions for Structure‐Based Virtual Screening , 2011 .

[33]  Adam R. Johnson,et al.  Lead optimization of a 4-aminopyridine benzamide scaffold to identify potent, selective, and orally bioavailable TYK2 inhibitors. , 2013, Journal of medicinal chemistry.

[34]  Samuel Genheden,et al.  Are Homology Models Sufficiently Good for Free-Energy Simulations? , 2012, J. Chem. Inf. Model..

[35]  Gert Vriend,et al.  GPCRDB information system for G protein-coupled receptors , 2003, Nucleic Acids Res..

[36]  Z. Xiang,et al.  On the role of the crystal environment in determining protein side-chain conformations. , 2002, Journal of molecular biology.

[37]  B. Honig,et al.  A hierarchical approach to all‐atom protein loop prediction , 2004, Proteins.

[38]  G. Klebe,et al.  Approaches to the Description and Prediction of the Binding Affinity of Small-Molecule Ligands to Macromolecular Receptors , 2002 .

[39]  David L. Mobley,et al.  Chapter 4 Alchemical Free Energy Calculations: Ready for Prime Time? , 2007 .

[40]  David L. Mobley,et al.  Guidelines for the analysis of free energy calculations , 2015, Journal of Computer-Aided Molecular Design.

[41]  Christopher J. Woods,et al.  Enhanced configurational sampling in binding free-energy calculations , 2003 .

[42]  Victor Guallar,et al.  Exploring hierarchical refinement techniques for induced fit docking with protein and ligand flexibility , 2009, J. Comput. Chem..

[43]  Pratyush Tiwary,et al.  Prediction of Protein-Ligand Binding Poses via a Combination of Induced Fit Docking and Metadynamics Simulations. , 2016, Journal of chemical theory and computation.

[44]  C. Higgs,et al.  Hydration Site Thermodynamics Explain SARs for Triazolylpurines Analogues Binding to the A2A Receptor. , 2010, ACS medicinal chemistry letters.

[45]  R. Zwanzig High‐Temperature Equation of State by a Perturbation Method. I. Nonpolar Gases , 1954 .

[46]  Anthony Nicholls,et al.  Confidence limits, error bars and method comparison in molecular modeling. Part 1: The calculation of confidence intervals , 2014, Journal of Computer-Aided Molecular Design.

[47]  Jennifer L. Knight,et al.  Accurate and reliable prediction of relative ligand binding potency in prospective drug discovery by way of a modern free-energy calculation protocol and force field. , 2015, Journal of the American Chemical Society.

[48]  R. Friesner,et al.  The VSGB 2.0 model: A next generation energy model for high resolution protein structure modeling , 2011, Proteins.

[49]  Woody Sherman,et al.  Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments , 2013, Journal of Computer-Aided Molecular Design.

[50]  William L Jorgensen,et al.  FEP-guided selection of bicyclic heterocycles in lead optimization for non-nucleoside inhibitors of HIV-1 reverse transcriptase. , 2006, Journal of the American Chemical Society.

[51]  Andrei L. Lomize,et al.  OPM: Orientations of Proteins in Membranes database , 2006, Bioinform..

[52]  Daniel Cappel,et al.  Accurate Binding Free Energy Predictions in Fragment Optimization , 2015, J. Chem. Inf. Model..

[53]  Julian Tirado-Rives,et al.  Computer-aided design of non-nucleoside inhibitors of HIV-1 reverse transcriptase. , 2006, Bioorganic & medicinal chemistry letters.

[54]  Michael J. Bodkin,et al.  Accurate calculation of the absolute free energy of binding for drug molecules , 2015, Chemical science.

[55]  S. Knapp,et al.  Discovery of Novel Small-Molecule Inhibitors of BRD4 Using Structure-Based Virtual Screening , 2013, Journal of medicinal chemistry.

[56]  Samuel Genheden,et al.  A Large-Scale Test of Free-Energy Simulation Estimates of Protein-Ligand Binding Affinities , 2014, J. Chem. Inf. Model..

[57]  T. Steinbrecher,et al.  Towards accurate free energy calculations in ligand protein-binding studies. , 2010, Current medicinal chemistry.

[58]  Johan Åqvist,et al.  Computational Prediction of Alanine Scanning and Ligand Binding Energetics in G-Protein Coupled Receptors , 2014, PLoS Comput. Biol..

[59]  Jonathan W. Essex,et al.  Monte Carlo Simulations for Proteins: Binding Affinities for Trypsin−Benzamidine Complexes via Free-Energy Perturbations , 1997 .

[60]  Charles L. Brooks,et al.  Community-wide assessment of GPCR structure modelling and ligand docking: GPCR Dock 2008 , 2009, Nature Reviews Drug Discovery.

[61]  David L Mobley,et al.  Nonlinear scaling schemes for Lennard-Jones interactions in free energy calculations. , 2007, The Journal of chemical physics.

[62]  Ross C Walker,et al.  Improving the Efficiency of Free Energy Calculations in the Amber Molecular Dynamics Package. , 2013, Journal of chemical theory and computation.

[63]  David Calkins,et al.  Towards the comprehensive, rapid, and accurate prediction of the favorable tautomeric states of drug-like molecules in aqueous solution , 2010, J. Comput. Aided Mol. Des..

[64]  David A. Case,et al.  Soft‐core potentials in thermodynamic integration: Comparing one‐ and two‐step transformations , 2011, J. Comput. Chem..

[65]  Brian A. Chauder,et al.  Discovery of potent myeloid cell leukemia 1 (Mcl-1) inhibitors using fragment-based methods and structure-based design. , 2013, Journal of medicinal chemistry.

[66]  P. Charifson,et al.  Are free energy calculations useful in practice? A comparison with rapid scoring functions for the p38 MAP kinase protein system. , 2001, Journal of medicinal chemistry.

[67]  Adam R. Johnson,et al.  Lead identification of novel and selective TYK2 inhibitors. , 2013, European journal of medicinal chemistry.

[68]  Scott P. Brown,et al.  Healthy skepticism: assessing realistic model performance. , 2009, Drug discovery today.

[69]  Woody Sherman,et al.  Current Assessment of Docking into GPCR Crystal Structures and Homology Models: Successes, Challenges, and Guidelines , 2012, J. Chem. Inf. Model..

[70]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[71]  Jeremy R. Greenwood,et al.  Epik: a software program for pKa prediction and protonation state generation for drug-like molecules , 2007, J. Comput. Aided Mol. Des..

[72]  Brian K Shoichet,et al.  Testing a flexible-receptor docking algorithm in a model binding site. , 2004, Journal of molecular biology.